维普期刊资源整合服务平台（V6.5）

26篇 您的检索式：作者名="AITHAL G P"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Risk of cardiovascular and cerebrovascular events in primary biliary cirrhosis: a population based cohort study显示文摘	Solaymani Dodaran M Aithal G P Card T West J	2008	Am J Gastroen terol2008，103，：	1
2	Guidelines on the management of ascites in cirrhosis 显示文摘	Moore K P Aithal G P	2006	Gut2006，55，6：	1
3	Association of polymorphisms in the cytochmme P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications 显示文摘	AITHAL G P DAY C P KESTENVEN P J	1999	Lancet1999，353，9154：	1
4	Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications显示文摘	Aithal G P Day C P Kesteven P J Daly A K	1999	Lancet1999，353，9154：	1
5	Hepatotoxicity related to antirheumatic drugs 显示文摘	AITHAL G P	2011	Nat Rev Rheumato12011，7，3：	1
6	Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications显示文摘	Aithal G Day C Kesteven P	1999	Lancet1999，353，：	1
7	Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications显示文摘	Aithal G P Day C P Kesteven P J	1999	Lancet1999，353，：	1
8	Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications 显示文摘	AITHAL G P DAV C P KESTEVEN P J	1999	Lancet1999，353，9154：	1
9	Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications 显示文摘	Aithal G P Day C P Kesteven P J	1999	Lancet1999，353，9154：	1
10	Guidelines on the management of ascites in cirrhosis显示文摘	MOORE K P AITHAL G P	2006	Gut2006，556，：	1
11	Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications显示文摘	AITHAL G P DAY C P KESTEVEN P J	1999	Lancet1999，353，：	1
12	Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis显示文摘	Aithal G P Thomas J A Kaye P V	2008	Gastroentero- logy2008，135，4：	1
13	Genetic susceptibility to diclofenac-induced hepatotoxicity:contribution of UGT2B7,CYP2C8,and ABCC2 genotypes显示文摘	Daly A K Aithal G P Leathart J B	2007	Gastroenterology2007，132，1：	1
14	Association of polymor- phisms in the cytochrome P450 CYP2C9 with warfarin dose require- ment and risk of bleeding complications 显示文摘	Aithal G P Day C P Kesteven P J	1999	Lancet1999，353，27：	1
15	Randomized,placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis显示文摘	Aithal G P Thomas J A Kaye P V	2008	Gastroenterology2008，135，4：	1
16	Performance Analysis of Centrifugal Pumps Subjected to Voltage Variation and Unbalance显示文摘	Kini P G Bansal R C Aithal R S	2008	IEEE Transactions on Industrial Electronics2008，55，2：	1
17	Diclofenac-induced liver injury:a paradigm of idiosyncratic drug toxicity显示文摘	AITHAL G P	2004	Expert Opin Drug Saf2004，3，6：	1
18	Association of polymorphism in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications显示文摘	AITHAL G P DAY C P KESTEVEN P J	1999	Lancet1999，353，：	1
19	A fast and novel skewestimation approach using radon transform显示文摘	Aithal P K Rajesh G Acharya D U	2013	InternationalJournal of Computer Information Systems and IndustrialManagement Applications2013，5，：	1
20	Randomized,placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis显示文摘	Aithal G P Thomas J A Kaye P V	2008	Gastroenterology2008，135，4：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示